These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 26994434

  • 21. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis.
    Fernandes BS, Steiner J, Molendijk ML, Dodd S, Nardin P, Gonçalves CA, Jacka F, Köhler CA, Karmakar C, Carvalho AF, Berk M.
    Lancet Psychiatry; 2016 Dec; 3(12):1147-1156. PubMed ID: 27838212
    [Abstract] [Full Text] [Related]

  • 22. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.
    Rowland T, Perry BI, Upthegrove R, Barnes N, Chatterjee J, Gallacher D, Marwaha S.
    Br J Psychiatry; 2018 Sep; 213(3):514-525. PubMed ID: 30113291
    [Abstract] [Full Text] [Related]

  • 23. Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood.
    Mesman E, Hillegers MH, Ambree O, Arolt V, Nolen WA, Drexhage HA.
    Bipolar Disord; 2015 Feb; 17(1):39-49. PubMed ID: 25039314
    [Abstract] [Full Text] [Related]

  • 24. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.
    Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill MK, Axelson DA, Birmaher B.
    J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):479-84. PubMed ID: 22040193
    [Abstract] [Full Text] [Related]

  • 25. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients.
    Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AGMR.
    Rev Assoc Med Bras (1992); 2019 Mar; 65(3):361-369. PubMed ID: 30994834
    [Abstract] [Full Text] [Related]

  • 26. Clinical staging and serum cytokines in bipolar patients during euthymia.
    Tatay-Manteiga A, Balanzá-Martínez V, Bristot G, Tabarés-Seisdedos R, Kapczinski F, Cauli O.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul 03; 77():194-201. PubMed ID: 28445689
    [Abstract] [Full Text] [Related]

  • 27. Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder.
    Rabie MA, Mohsen M, Ibrahim M, El-Sawy Mahmoud R.
    J Affect Disord; 2014 Jun 03; 162():67-72. PubMed ID: 24767008
    [Abstract] [Full Text] [Related]

  • 28. Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: an open-label trial in drug-free patients with bipolar disorder.
    Grande I, Kapczinski F, Stertz L, Colpo GD, Kunz M, Cereser KM, Kauer-Sant'Anna M, Frey B, Vieta E, Magalhaes PV.
    J Psychiatr Res; 2012 Nov 03; 46(11):1511-4. PubMed ID: 22939945
    [Abstract] [Full Text] [Related]

  • 29. Peripheral inflammation during abnormal mood states in bipolar I disorder.
    Fiedorowicz JG, Prossin AR, Johnson CP, Christensen GE, Magnotta VA, Wemmie JA.
    J Affect Disord; 2015 Nov 15; 187():172-8. PubMed ID: 26339927
    [Abstract] [Full Text] [Related]

  • 30. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P, Andreassen OA.
    J Psychiatr Res; 2011 Dec 15; 45(12):1608-16. PubMed ID: 21889167
    [Abstract] [Full Text] [Related]

  • 31. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z, Zhang C, Fan J, Yuan C, Huang J, Chen J, Yi Z, Wang Z, Hong W, Wang Y, Lu W, Guan Y, Wu Z, Su Y, Cao L, Hu Y, Hao Y, Liu M, Yu S, Cui D, Xu L, Song Y, Fang Y.
    Br J Psychiatry; 2014 Jul 15; 205(1):29-35. PubMed ID: 24764546
    [Abstract] [Full Text] [Related]

  • 32. Leukocytes in peripheral blood in patients with bipolar disorder - Trait and state alterations and association with levels of cytokines and C-reactive protein.
    Munkholm K, Jacoby AS, Lenskjold T, Bruunsgaard H, Vinberg M, Kessing LV.
    Psychiatry Res; 2018 Mar 15; 261():383-390. PubMed ID: 29353768
    [Abstract] [Full Text] [Related]

  • 33. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders.
    Monteleone P, Serritella C, Martiadis V, Maj M.
    Bipolar Disord; 2008 Feb 15; 10(1):95-100. PubMed ID: 18199246
    [Abstract] [Full Text] [Related]

  • 34. Comparison of serum BDNF, IL-1β, IL-6, TNF-α, CRP and leucocyte levels in unipolar mania and bipolar disorder.
    Gorgulu Y, Uluturk MK, Palabiyik O.
    Acta Neuropsychiatr; 2021 Dec 15; 33(6):317-322. PubMed ID: 34462030
    [Abstract] [Full Text] [Related]

  • 35. Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression.
    Panizzutti B, Bortolasci C, Hasebe K, Kidnapillai S, Gray L, Walder K, Berk M, Mohebbi M, Dodd S, Gama C, Magalhães PV, Cotton SM, Kapczinski F, Bush AI, Malhi GS, Dean OM.
    Acta Neuropsychiatr; 2018 Dec 15; 30(6):334-341. PubMed ID: 30008280
    [Abstract] [Full Text] [Related]

  • 36. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
    Karthikeyan S, Dimick MK, Fiksenbaum L, Jeong H, Birmaher B, Kennedy JL, Lanctôt K, Levitt AJ, Miller GE, Schaffer A, Young LT, Youngstrom EA, Andreazza AC, Goldstein BI.
    Brain Behav Immun; 2022 Feb 15; 100():278-286. PubMed ID: 34896179
    [Abstract] [Full Text] [Related]

  • 37. Shortening of telomere length may be associated with inflammatory cytokine levels in patients with bipolar disorder.
    Wang SM, Chang HH, Chang YH, Tsai TY, Chen PS, Lu RB, Wang TY.
    J Affect Disord; 2024 Nov 15; 365():155-161. PubMed ID: 39153550
    [Abstract] [Full Text] [Related]

  • 38. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode.
    Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y.
    J Affect Disord; 2015 Mar 15; 174():361-6. PubMed ID: 25545602
    [Abstract] [Full Text] [Related]

  • 39. Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes.
    Becking K, Spijker AT, Hoencamp E, Penninx BW, Schoevers RA, Boschloo L.
    PLoS One; 2015 Mar 15; 10(7):e0133898. PubMed ID: 26196286
    [Abstract] [Full Text] [Related]

  • 40. High BDNF serum levels are associated to good cognitive functioning in bipolar disorder.
    Mora E, Portella MJ, Piñol-Ripoll G, López R, Cuadras D, Forcada I, Teres M, Vieta E, Mur M.
    Eur Psychiatry; 2019 Aug 15; 60():97-107. PubMed ID: 30808582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.